Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-04-30
2009-12-15
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S046000, C536S027600
Reexamination Certificate
active
07632825
ABSTRACT:
Methods of providing pain relief by administering a water-soluble derivative of spicamycin. Methods of using pain mediation agents are also provided.
REFERENCES:
patent: 5252463 (1993-10-01), Nelson et al.
patent: 5905069 (1999-05-01), Borsook et al.
patent: 6087091 (2000-07-01), Justice et al.
patent: 7196071 (2007-03-01), Borsook
patent: 0525479 (1993-02-01), None
Supplementary European Search Report for EP01971222 mailed Sep. 12, 2005.
Kamishohara et al., “Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells,” Oncol Res 1994; 6:383-90.
Vilassova N. et al., “The Effects of KRN5500, a Spicamycin derivative, on Neuropathic and Nocicieptive Pain Models in Rats.”,Database PubMed, US National Library of Medicine, No. 11004056, Abstract 2000.
Bayer Pharmaceuticals Corporation
Henry Michael C
Jiang Shaojia Anna
Myers Bigel & Sibley Sajovec, PA
LandOfFree
Methods of decreasing or preventing pain using spicamycin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of decreasing or preventing pain using spicamycin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of decreasing or preventing pain using spicamycin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4126260